Dark Horse Consulting Group (“DHCG” or “the Group”), a leader in strategic and operational consulting in advanced therapies—specifically the fields of cell and gene therapy (“CGT”) and biotherapeutics—is delighted to announce the acquisition of Converge Consulting, LLC (Converge). Converge is known for its ability to bridge the gap between sound strategy and reliable execution for biopharmaceutical organizations in the areas of supply chain, manufacturing, commercial launch readiness, operational excellence, enterprise IT solutions, CMC, and Quality. With offices located in North America, Europe, and APAC, DHCG is a fully integrated global consulting practice offering a range of strategic and operational services to biopharma markets.
Read the full article: Dark Horse Consulting Group Acquires Converge Consulting //
Source: https://www.globenewswire.com/news-release/2025/09/18/3152622/0/en/Dark-Horse-Consulting-Group-Acquires-Converge-Consulting.html